A Class Action Lawsuit Has Been Filed by Longman Law, P.C.

LIVINGSTON, NJ, June 29, 2021 (GLOBE NEWSWIRE) – Longman Law, PC has filed a class action lawsuit against Athira Pharma, Inc. (“Athira”) (NASDAQ: ATHA), some of its officers and directors, and the underwriters of the IPO Athira common stock titled Timothy Slyne et al. v. Athira Pharma, Inc., et al., CA 2: 21-cv-00864, ​​(WD Wash.) On behalf of buyers of ATHA common stock either in its initial public offering in September 2020 or in purchasing its stock in the open market, which can be traced back to the IPO. Our co-counsel is the nationally recognized law firm Keller Rohrback, LLP. The lawsuit seeks appeals under the Securities Act of 1933.

If you have purchased or acquired ATHA common stock in accordance with the IPO or are traceable to it and you wish to serve as the lead plaintiff, you can take the court no later than August 24, 2021. A lead plaintiff is a representative party who acts on behalf of another class of members in litigation.

The lawsuit alleges that the defendants misrepresented and omitted important truths in the company’s IPO registration statement regarding Athira’s CEO and President Leen Kawas. When the company announced after close of trading on June 17, 2021 that the board of directors of Athira Dr. Kawas was on temporary leave because it was alleged that Dr. Forging Kawa’s research in various academic papers, Athira’s stock plunged about 40% from $ 18.24 to $ 11.15 per share, well below its IPO price of $ 17.00, causing harm to all of them who have purchased or are traceable to Athira common stock pursuant to the IPO.

Howard Longman has served as a lawyer representing plaintiffs in securities class actions for over thirty years. As lead counsel on many of these cases, he has collected hundreds of millions of dollars on behalf of investors in numerous class action lawsuits. For more information or to join the lawsuit, visit Longman.Law and contact Howard at [email protected] or Adam Longman at the same email address. We can also be reached by phone at (973) 994-2315.

Lawyer advertising. Previous results do not guarantee a similar result. This press release may be viewed as a solicitation in some jurisdictions subject to applicable laws and ethical rules.

Comments are closed.